Korea United Pharm Inc. (033270.KS) KSC

19,670.00

-100(-0.51%)

Updated at December 05 03:19PM

Currency In KRW

Valuation

Market Cap267.54B
Enterprise Value249.49B
P/E Ratio8.52
PEG Ratio0.29
Price/Sales Ratio1.01
Price/Book Ratio0.69
Enterprise/Revenue0.98
Enterprise/EBITDA4.83

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.12
Operating Margin0.18

Management Effectiveness

Return On Assets0.07
Return On Equity0.08

Income Statement

Revenue288.71B
Revenue/Share19,643.3
Gross Profit163.97B
EBITDA57.84B
Net Income32.45B
Diluted EPS2,205.77

Balance Sheet

Total Cash130.49B
Total Cash/Share8,954.34
Total Debt14.95B
Total Debt/Equity0.04
Current Ratio5.44
Book Value Per Share28,386.76

Price History

52-Week Change6.41
52-Week High22,450
52-Week Low17,250
Moving Average 50 Days19,172.8
Moving Average 200 Days19,992.9

Statistics

Average Volume40,680
Shares Outstanding14.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate450
Trailing Annual Dividend Yield2.3
Payout Ratio0
Last Split Factor51:50
Last Split DateJanuary 20, 2014